Management of Paracetamol Poisoning
Administer N-acetylcysteine (NAC) to all patients with acute paracetamol overdose who fall above the treatment line on the Rumack-Matthew nomogram, ideally within 8 hours of ingestion, using a two-bag regimen (200 mg/kg over 4 hours, then 100 mg/kg over 16 hours) which has similar efficacy but significantly fewer adverse reactions than older protocols 1, 2.
Risk Stratification and Treatment Indications
Acute Single Ingestion (Known Time, <24 Hours)
For patients presenting 4-24 hours after a single acute ingestion:
- Obtain serum paracetamol concentration at 4 hours post-ingestion or later and plot on the Rumack-Matthew nomogram 1
- Start NAC if the concentration falls at or above the treatment line (indicating possible or probable risk for hepatotoxicity) 1
- Do NOT administer NAC if concentration falls below the treatment line (no risk for hepatotoxicity) 1
Critical timing consideration: Patients treated within 8 hours had no severe hepatotoxicity in landmark studies, while those treated between 8-10 hours had minimal toxicity. However, patients treated after 10 hours had a 53% incidence of severe hepatotoxicity with 5% mortality 1. This creates an urgent 8-10 hour window for optimal intervention.
High-Risk Ingestions (Massive Overdose)
Recent consensus guidelines have replaced the term "massive ingestion" with "high-risk ingestion" 3:
- Defined as paracetamol concentrations more than double the nomogram treatment line 2
- Requires increased NAC dosing: Continue the standard two-bag regimen but extend treatment duration based on clinical parameters 2
- For ingestions ≥30 g or ≥500 mg/kg, administer increased doses of acetylcysteine 2
Repeated Supratherapeutic Ingestions
This represents a unique clinical scenario with worse prognosis than acute overdose 1. Approximately 30% of paracetamol overdose admissions involve this pattern 1.
Refer to emergency department if 3, 4:
- ≥200 mg/kg or 10 g (whichever is less) within any 24-hour period
- ≥150 mg/kg/24h or 6 g/day (whichever is less) within 48 hours
- ≥100 mg/kg/24h or 4 g/day (whichever is less) for more than 48 hours
Lower thresholds (4 g or 100 mg/kg) apply for high-risk patients: those on isoniazid, prolonged fasting, or chronic alcohol use 1.
Cannot use the Rumack-Matthew nomogram for risk stratification in these cases 1. Instead, treat all potentially toxic repeated supratherapeutic ingestions with a full course of NAC.
NAC Dosing Regimens
Standard Two-Bag Regimen (Preferred)
The two-bag regimen has replaced older three-bag protocols 2:
- First bag: 200 mg/kg IV over 4 hours
- Second bag: 100 mg/kg IV over 16 hours
Total treatment duration: 20 hours (compared to 21-24 hours with older regimens)
This regimen demonstrates significantly reduced adverse reactions with equivalent efficacy compared to the traditional three-bag regimen 2.
SNAP Regimen (Emerging Alternative)
A newer protocol uses 300 mg/kg over 12 hours with option to extend 5:
- 70% of patients require only 12 hours of treatment 5
- Stop criteria: If paracetamol concentration <10 mg/L, ALT <100 U/L, and INR ≤1.3, discontinue NAC 5
- Fewer side effects and reduced hospital stay compared to traditional protocols 5
Special Populations
Modified-Release Formulations
- All potentially toxic ingestions (≥10 g or ≥200 mg/kg) require full NAC course 2
- Cannot reliably use nomogram due to delayed absorption kinetics 2
- For ingestions ≥30 g or ≥500 mg/kg, use increased NAC doses 2
Pregnancy
- Treat pregnant women with same NAC indications and dosing as non-pregnant patients 3
- NAC crosses the placenta and protects both mother and fetus
- Risk of hepatotoxicity outweighs any theoretical NAC risks
Obesity (>100 kg)
- Use actual body weight for NAC dosing calculations 3
- Do not cap doses based on ideal body weight
Children <6 Years
- Apply same treatment principles but with age-appropriate thresholds 3
- Accidental liquid paracetamol ingestions require careful dose calculation
Adjunctive Management
Gastrointestinal Decontamination
- Administer activated charcoal if patient presents within 1-2 hours of ingestion 2
- Dose: 50 g for adults, 1 g/kg for children
- Do not delay NAC administration to give charcoal
Laboratory Monitoring
Initial evaluation 3:
- Serum paracetamol concentration (at 4+ hours post-ingestion)
- AST, ALT
- INR/PT
- Creatinine
- Consider pregnancy test in women of childbearing age
Serial monitoring during NAC treatment:
- Repeat paracetamol level, transaminases, INR every 12-24 hours
- Continue until paracetamol undetectable and liver function improving
Stopping Criteria for NAC
Discontinue NAC when ALL of the following are met 5:
- Paracetamol concentration <10 mg/L (or undetectable)
- ALT <100 U/L (or normal and trending down)
- INR ≤1.3
If criteria not met at end of standard regimen, continue NAC infusion at 100 mg/kg/16h and reassess every 12 hours 2.
Common Pitfalls to Avoid
Do not wait for symptoms before treating: Hepatotoxicity develops 24-72 hours post-ingestion, well after the optimal treatment window 1
Do not use the nomogram for: repeated supratherapeutic ingestions, unknown time of ingestion, presentations >24 hours, or modified-release formulations 1, 2
Do not underdose NAC in obesity: Use actual body weight, not ideal body weight 3
Do not stop NAC prematurely: Ensure all stopping criteria are met before discontinuation 5
Do not miss coingestions: Anticholinergics and opioids can delay gastric emptying and paracetamol absorption 3
When to Consult Clinical Toxicology
Immediate consultation indicated for 3:
- High-risk ingestions (concentrations >2x nomogram line)
- Presentations >24 hours with elevated transaminases
- Pregnancy with toxic ingestion
- Acute liver failure (INR >2.0, encephalopathy)
- Consideration for extracorporeal elimination or transplant evaluation
FDA Warning Context
The FDA label emphasizes that severe liver damage occurs with >4000 mg daily in adults or when combined with alcohol (≥3 drinks/day) 6. In overdose, quick medical attention is critical even without symptoms, as hepatotoxicity manifests with delay 6.